Assess the data and tweets to estimate whether the closing price of $bmy will escalate or deflate at 2017-07-28. Respond with either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-07-14,-0.6,0.5,-1.2,0.9,0.9,0.1,0.6,0.8,0.7,0.1,-0.7
2017-07-17,0.9,1.4,-0.4,-0.7,-0.7,0.4,1.2,1.3,1.4,0.9,-0.1
2017-07-18,0.1,0.1,-0.6,-0.1,-0.1,0.3,1.1,1.2,1.5,1.0,0.2
2017-07-19,-0.5,0.2,-0.8,0.6,0.6,-0.3,0.2,0.5,0.9,0.5,-0.2
2017-07-20,-0.3,0.5,-0.5,0.7,0.7,-0.7,-0.4,-0.2,0.2,-0.1,-0.6
2017-07-21,-0.4,0.2,-0.5,0.4,0.4,-0.9,-0.8,-0.5,-0.3,-0.3,-0.8
2017-07-24,0.1,0.6,-0.8,-0.1,-0.1,-0.5,-0.8,-0.4,-0.3,-0.1,-0.6
2017-07-25,-0.2,0.4,-0.3,0.6,0.6,-0.7,-1.3,-1.0,-0.9,-0.7,-1.1
2017-07-26,-0.1,0.3,-0.9,0.1,0.1,-0.5,-1.2,-1.1,-0.9,-0.7,-1.0
2017-07-27,-1.7,0.4,-4.0,-3.1,-3.1,2.3,1.9,2.0,2.1,2.4,2.2

2017-07-14: s&amp;p100 #stocks performance $gd $amgn $msft $nee $rtn $bmy $celg $cat $fdx $jnj $pcln $mdt $dis $agn $intc  more@ |bristol-myers squibb company $bmy position reduced by janney montgomery scott llc 
2017-07-15: putting $bmy on my watchlist.  will wait for macd to turn up.  AT_USER |polaris greystone financial group llc purchases shares of 277,844 bristol-myers squibb company $bmy |$bmy - sell signal at 56.12
2017-07-16: see for yourself! $twx $azn $bmy $aapl $nflx $orcl $kite $halo $ipxl $dis $gm $ge $grub $shak $cake $pypl $juno¡­ |rt AT_USER big pharma share prices jumped in the first half, except for $bmy  #pharma
2017-07-17: bristol-myers squibb company $bmy price target raised to $55.00 at deutsche bank ag |??? $agn $ibm $msft $crm $twtr $ge $gm $fb $nflx $myl $snap $orcl $goog $googl $cost $wmt $wfm $gpro $grub $shak¡­ 
2017-07-18: $bmy $mrk |3 healthcare stocks threatened by the collapse of ¡®trumpcare¡¯   $xlv $abc $prgo $bmy AT_USER|he jinxed $bmy in 2016 #cramerkissofdeath |rt AT_USER hurt by a drug? you can sue in californi
2017-07-19: tower bridge advisors reduces position in bristol-myers squibb company $bmy |rt AT_USER leerink's fernandez says $mrk's keytruda's gains against $bmy's opdivo are accelerating |#cboscore $spy $ci $hum
2017-07-20: rt AT_USER $bmy flagging &gt;200dma |rt AT_USER $bmy flagging &gt;200dma |$bmy flagging &gt;200dma |$bmy is in ema33 breakout winning 63.01% in the past.  |q2 2017 eps estimates for bristol-myers squi
2017-07-21: rt AT_USER bristol myers $bmy with 5k aug. 4th (w) $60 calls bought, earlier this week 5k each of the $56 and $57 calls opened|rt AT_USER next week is going to be fun. $gild is wednesday and then both
2017-07-22: #biotech exec, with #cancer, on new drug expectations   #immunotherapy #cancerresearch¡­ |little upside for bristol-myers squibb company $bmy investors prior to earnings next thursday¡­ |rt AT_USER go
2017-07-23: bmy early trade bull, about to breakout $bmy |some names with er this week $hal $has $goog $aks $gm $stx $mcd $cat $fcx $jblu $mmm $biib $lly $exas $dd $f $ba $ko $twtr $clf $bmy $ma|rt AT_USER 3 thin
2017-07-24: rt AT_USER fda accepts $bmy's applications for opdivo 4-week dosing schedule across all approved indications. |s&amp;p100 #stocks performance $gd $amgn $msft $nee $rtn $bmy $celg $cat $fdx $jnj $pcln 
2017-07-25: #bristolmyerssquibb how bristol could put the hurt on dow's merck in immuno-oncology. read more:  $bmy|#bristolmyerssquibb fda accepts bristol-myers squibb???s applications for opdivo (nivolumab)... r
2017-07-26: rt AT_USER join us tomorrow at 10:30am edt for our q2 earnings call &amp; follow us here for live tweets. learn more: |commented on gilead puts up the good fight once again  $bmy $gsk $pfe $gild|rt AT
2017-07-27: $bmy declines -3.1% on q2 earnings vs an expected ¡à3.5% move according to the 28-jul-17 options straddle |#bristolmyerssquibb astrazeneca cancer drug failure doesn't bode well for bristol myers. read
Answer:
Assess the data and tweets to estimate whether the closing price of $bmy will escalate or deflate at 2017-07-28. Respond with either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-07-14,-0.6,0.5,-1.2,0.9,0.9,0.1,0.6,0.8,0.7,0.1,-0.7
2017-07-17,0.9,1.4,-0.4,-0.7,-0.7,0.4,1.2,1.3,1.4,0.9,-0.1
2017-07-18,0.1,0.1,-0.6,-0.1,-0.1,0.3,1.1,1.2,1.5,1.0,0.2
2017-07-19,-0.5,0.2,-0.8,0.6,0.6,-0.3,0.2,0.5,0.9,0.5,-0.2
2017-07-20,-0.3,0.5,-0.5,0.7,0.7,-0.7,-0.4,-0.2,0.2,-0.1,-0.6
2017-07-21,-0.4,0.2,-0.5,0.4,0.4,-0.9,-0.8,-0.5,-0.3,-0.3,-0.8
2017-07-24,0.1,0.6,-0.8,-0.1,-0.1,-0.5,-0.8,-0.4,-0.3,-0.1,-0.6
2017-07-25,-0.2,0.4,-0.3,0.6,0.6,-0.7,-1.3,-1.0,-0.9,-0.7,-1.1
2017-07-26,-0.1,0.3,-0.9,0.1,0.1,-0.5,-1.2,-1.1,-0.9,-0.7,-1.0
2017-07-27,-1.7,0.4,-4.0,-3.1,-3.1,2.3,1.9,2.0,2.1,2.4,2.2

2017-07-14: s&amp;p100 #stocks performance $gd $amgn $msft $nee $rtn $bmy $celg $cat $fdx $jnj $pcln $mdt $dis $agn $intc  more@ |bristol-myers squibb company $bmy position reduced by janney montgomery scott llc 
2017-07-15: putting $bmy on my watchlist.  will wait for macd to turn up.  AT_USER |polaris greystone financial group llc purchases shares of 277,844 bristol-myers squibb company $bmy |$bmy - sell signal at 56.12
2017-07-16: see for yourself! $twx $azn $bmy $aapl $nflx $orcl $kite $halo $ipxl $dis $gm $ge $grub $shak $cake $pypl $juno¡­ |rt AT_USER big pharma share prices jumped in the first half, except for $bmy  #pharma
2017-07-17: bristol-myers squibb company $bmy price target raised to $55.00 at deutsche bank ag |??? $agn $ibm $msft $crm $twtr $ge $gm $fb $nflx $myl $snap $orcl $goog $googl $cost $wmt $wfm $gpro $grub $shak¡­ 
2017-07-18: $bmy $mrk |3 healthcare stocks threatened by the collapse of ¡®trumpcare¡¯   $xlv $abc $prgo $bmy AT_USER|he jinxed $bmy in 2016 #cramerkissofdeath |rt AT_USER hurt by a drug? you can sue in californi
2017-07-19: tower bridge advisors reduces position in bristol-myers squibb company $bmy |rt AT_USER leerink's fernandez says $mrk's keytruda's gains against $bmy's opdivo are accelerating |#cboscore $spy $ci $hum
2017-07-20: rt AT_USER $bmy flagging &gt;200dma |rt AT_USER $bmy flagging &gt;200dma |$bmy flagging &gt;200dma |$bmy is in ema33 breakout winning 63.01% in the past.  |q2 2017 eps estimates for bristol-myers squi
2017-07-21: rt AT_USER bristol myers $bmy with 5k aug. 4th (w) $60 calls bought, earlier this week 5k each of the $56 and $57 calls opened|rt AT_USER next week is going to be fun. $gild is wednesday and then both
2017-07-22: #biotech exec, with #cancer, on new drug expectations   #immunotherapy #cancerresearch¡­ |little upside for bristol-myers squibb company $bmy investors prior to earnings next thursday¡­ |rt AT_USER go
2017-07-23: bmy early trade bull, about to breakout $bmy |some names with er this week $hal $has $goog $aks $gm $stx $mcd $cat $fcx $jblu $mmm $biib $lly $exas $dd $f $ba $ko $twtr $clf $bmy $ma|rt AT_USER 3 thin
2017-07-24: rt AT_USER fda accepts $bmy's applications for opdivo 4-week dosing schedule across all approved indications. |s&amp;p100 #stocks performance $gd $amgn $msft $nee $rtn $bmy $celg $cat $fdx $jnj $pcln 
2017-07-25: #bristolmyerssquibb how bristol could put the hurt on dow's merck in immuno-oncology. read more:  $bmy|#bristolmyerssquibb fda accepts bristol-myers squibb???s applications for opdivo (nivolumab)... r
2017-07-26: rt AT_USER join us tomorrow at 10:30am edt for our q2 earnings call &amp; follow us here for live tweets. learn more: |commented on gilead puts up the good fight once again  $bmy $gsk $pfe $gild|rt AT
2017-07-27: $bmy declines -3.1% on q2 earnings vs an expected ¡à3.5% move according to the 28-jul-17 options straddle |#bristolmyerssquibb astrazeneca cancer drug failure doesn't bode well for bristol myers. read
Answer:+Rise